QQ客服 官方微博 反馈留言

	GSK-3 beta inhibitor 6-bromo-indirubin-3'-oxime promotes both adhesive activity and drug resistance in colorectal cancer cells
	Liu, Kunping[1,2]; Li, Jinbang[1,2]; Wu, Xuefang[1,2]; Chen, Meixiang[1,2]; Luo, Feng[1,2]; Li, Jun[3]
	2017
卷号	51期号:6页码:1821
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4755383
专题	暨南大学
作者单位	1.[1]Guangzhou Med Univ, Qingyuan Peoples Hosp, Affiliated Hosp 6, Dept Pathol, Qingyuan 511518, Guangdong, Peoples R China 2.[2]Jinan Univ, Qingyuan Peoples Hosp, Dept Pathol, Qingyuan 511518, Guangdong, Peoples R China 3.[3]Guangzhou Med Univ, Affiliated Hosp 1, Dept Gen Surg, Guangzhou 510120, Guangdong, Peoples R China
推荐引用方式 GB/T 7714	Liu, Kunping[1,2],Li, Jinbang[1,2],Wu, Xuefang[1,2],et al. GSK-3 beta inhibitor 6-bromo-indirubin-3'-oxime promotes both adhesive activity and drug resistance in colorectal cancer cells[J],2017,51(6):1821.
APA	Liu, Kunping[1,2],Li, Jinbang[1,2],Wu, Xuefang[1,2],Chen, Meixiang[1,2],Luo, Feng[1,2],&Li, Jun[3].(2017).GSK-3 beta inhibitor 6-bromo-indirubin-3'-oxime promotes both adhesive activity and drug resistance in colorectal cancer cells.,51(6),1821.
MLA	Liu, Kunping[1,2],et al."GSK-3 beta inhibitor 6-bromo-indirubin-3'-oxime promotes both adhesive activity and drug resistance in colorectal cancer cells".51.6(2017):1821.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。